| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.972 | 0.002 | 0.972 | Aldehyde oxidase inhibitor | 0.662 0.012 CID_154699525 | ||
| 0.9 | 0.004 | 0.9 | Aryl hydrocarbon receptor agonist | 0.397 0.038 CID_154699525 | ||
| 0.869 | 0.004 | 0.869 | 12-Lipoxygenase inhibitor | 0.184 0.169 CID_154699525 | ||
| 0.858 | 0.005 | 0.858 | 15-Lipoxygenase inhibitor | |||
| 0.843 | 0.006 | 0.843 | Caspase 9 stimulant | 0.826 0.008 CID_154699525 | ||
| 0.772 | 0.003 | 0.772 | MAO A inhibitor | 0.107 0.06 CID_154699525 | ||
| 0.765 | 0.002 | 0.765 | Aldehyde dehydrogenase inhibitor | 0.748 0.002 CID_154699525 | ||
| 0.766 | 0.004 | 0.766 | MAO inhibitor | |||
| 0.752 | 0.005 | 0.752 | Caspase 3 stimulant | 0.626 0.009 CID_154699525 | ||
| 0.743 | 0.005 | 0.743 | Lipoxygenase inhibitor | 0.212 0.128 CID_154699525 | ||
| 0.758 | 0.022 | 0.778 | Apoptosis agonist | 0.778 0.019 CID_154699525 | CID_154699525 | |
| 0.725 | 0.003 | 0.873 | Melanin inhibitor | 0.873 0.001 CID_154699525 | CID_154699525 | |
| 0.715 | 0.004 | 0.715 | Breast cancer-resistant protein inhibitor | 0.195 0.014 CID_154699525 | ||
| 0.715 | 0.005 | 0.81 | Antioxidant | 0.81 0.004 CID_154699525 | CID_154699525 | |
| 0.705 | 0.004 | 0.708 | Hypoxia-inducible factor 1 alpha inhibitor | 0.708 0.004 CID_154699525 | CID_154699525 | |
| 0.688 | 0.004 | 0.906 | Monophenol monooxygenase inhibitor | 0.906 0.002 CID_154699525 | CID_154699525 | |
| 0.685 | 0.004 | 0.685 | MAO B inhibitor | |||
| 0.677 | 0.004 | 0.677 | NOS3 expression enhancer | 0.648 0.004 CID_154699525 | ||
| 0.705 | 0.033 | 0.869 | Alpha-glucosidase inhibitor | 0.869 0.01 CID_154699525 | CID_154699525 | |
| 0.682 | 0.023 | 0.889 | Transcription factor NF kappa B inhibitor | 0.889 0.007 CID_154699525 | CID_154699525 | |
| 0.658 | 0.006 | 0.733 | Free radical scavenger | 0.733 0.005 CID_154699525 | CID_154699525 | |
| 0.637 | 0.002 | 0.637 | CF transmembrane conductance regulator agonist | 0.395 0.003 CID_154699525 | ||
| 0.629 | 0.004 | 0.808 | Amylase inhibitor | 0.808 0.002 CID_154699525 | CID_154699525 | |
| 0.625 | 0.003 | 0.625 | NADPH oxidase inhibitor | 0.557 0.004 CID_154699525 | ||
| 0.597 | 0.008 | 0.597 | Amyloid beta aggregation inhibitor | 0.432 0.021 CID_154699525 | ||
| 0.592 | 0.004 | 0.592 | Pyruvate kinase inhibitor | 0.295 0.049 CID_154699525 | ||
| 0.586 | 0.002 | 0.586 | Histidine decarboxylase inhibitor | 0.211 0.012 CID_154699525 | ||
| 0.572 | 0.003 | 0.572 | Cystathionine beta-synthase inhibitor | 0.451 0.004 CID_154699525 | ||
| 0.572 | 0.005 | 0.572 | Peroxidase inhibitor | |||
| 0.575 | 0.01 | 0.575 | GABA C receptor rho-3 antagonist | |||
| 0.545 | 0.011 | 0.808 | Vasodilator, coronary | 0.808 0.004 CID_154699525 | CID_154699525 | |
| 0.546 | 0.017 | 0.654 | Histamine release inhibitor | 0.654 0.006 CID_154699525 | CID_154699525 | |
| 0.523 | 0.006 | 0.523 | Topoisomerase II inhibitor | 0.515 0.006 CID_154699525 | ||
| 0.514 | 0.003 | 0.514 | Macrophage migration inhibitory factor inhibitor | 0.157 0.013 CID_154699525 | ||
| 0.507 | 0.004 | 0.687 | Xanthine oxidase inhibitor | 0.687 0.003 CID_154699525 | CID_154699525 | |
| 0.52 | 0.038 | 0.52 | Prostaglandin dehydrogenase inhibitor | |||
| 0.493 | 0.035 | 0.595 | 5 Hydroxytryptamine release inhibitor | 0.595 0.012 CID_154699525 | CID_154699525 | |
| 0.474 | 0.024 | 0.592 | Apoptosis antagonist | 0.592 0.01 CID_154699525 | CID_154699525 | |
| 0.451 | 0.004 | 0.451 | Estrogen receptor alpha antagonist | |||
| 0.525 | 0.078 | 0.79 | Antiinflammatory | 0.79 0.017 CID_154699525 | CID_154699525 | |
| 0.459 | 0.019 | 0.583 | Nitric oxide antagonist | 0.583 0.011 CID_154699525 | CID_154699525 | |
| 0.444 | 0.008 | 0.444 | Bone formation stimulant | 0.313 0.015 CID_154699525 | ||
| 0.453 | 0.02 | 0.701 | Hypoglycemic | 0.701 0.005 CID_154699525 | CID_154699525 | |
| 0.452 | 0.021 | 0.548 | Antiamyloidogenic | 0.548 0.012 CID_154699525 | CID_154699525 | |
| 0.44 | 0.012 | 0.44 | P-glycoprotein inhibitor | 0.325 0.025 CID_154699525 | ||
| 0.427 | 0.005 | 0.427 | Heat shock protein 90 alpha antagonist | |||
| 0.425 | 0.004 | 0.772 | Beta glucuronidase inhibitor | 0.772 0.002 CID_154699525 | CID_154699525 | |
| 0.42 | 0.003 | 0.42 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.119 0.029 CID_154699525 | ||
| 0.415 | 0.003 | 0.415 | Interleukin 5 antagonist | 0.257 0.004 CID_154699525 | ||
| 0.409 | 0.004 | 0.409 | Estrogen receptor beta antagonist | 0.123 0.029 CID_154699525 | ||
| 0.425 | 0.023 | 0.546 | Tumour necrosis factor alpha release inhibitor | 0.546 0.01 CID_154699525 | CID_154699525 | |
| 0.412 | 0.012 | 0.599 | Hepatoprotectant | 0.599 0.005 CID_154699525 | CID_154699525 | |
| 0.4 | 0.005 | 0.4 | Estrogen antagonist | 0.169 0.018 CID_154699525 | ||
| 0.415 | 0.025 | 0.417 | DNA damaging | 0.417 0.025 CID_154699525 | CID_154699525 | |
| 0.39 | 0.002 | 0.39 | DOPA decarboxylase inhibitor | 0.158 0.018 CID_154699525 | ||
| 0.394 | 0.012 | 0.394 | Tubulin antagonist | 0.127 0.074 CID_154699525 | ||
| 0.44 | 0.06 | 0.696 | Antibacterial | 0.696 0.009 CID_154699525 | CID_154699525 | |
| 0.384 | 0.005 | 0.384 | Topoisomerase II alpha inhibitor | 0.375 0.005 CID_154699525 | ||
| 0.383 | 0.005 | 0.383 | Heat shock protein 90 antagonist | 0.176 0.051 CID_154699525 | ||
| 0.384 | 0.006 | 0.385 | Alkaline phosphatase inhibitor | 0.385 0.006 CID_154699525 | CID_154699525 | |
| 0.411 | 0.038 | 0.553 | Spasmolytic | 0.553 0.018 CID_154699525 | CID_154699525 | |
| 0.376 | 0.004 | 0.376 | Alcohol dehydrogenase inhibitor | 0.328 0.005 CID_154699525 | ||
| 0.398 | 0.027 | 0.398 | Superoxide dismutase inhibitor | |||
| 0.39 | 0.019 | 0.39 | RNA-directed DNA polymerase inhibitor | 0.291 0.033 CID_154699525 | ||
| 0.373 | 0.008 | 0.373 | Acetylcholinesterase inhibitor | 0.137 0.064 CID_154699525 | ||
| 0.373 | 0.011 | 0.439 | Lipid peroxidase inhibitor | 0.439 0.008 CID_154699525 | CID_154699525 | |
| 0.379 | 0.034 | 0.379 | Interleukin antagonist | 0.228 0.071 CID_154699525 | ||
| 0.356 | 0.012 | 0.356 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.249 0.043 CID_154699525 | ||
| 0.343 | 0.005 | 0.343 | Estrogen agonist | 0.218 0.007 CID_154699525 | ||
| 0.342 | 0.01 | 0.342 | Amyloid beta precursor protein antagonist | 0.169 0.082 CID_154699525 | ||
| 0.33 | 0.003 | 0.33 | Papain-like protease (SARS coronavirus) inhibitor | 0.208 0.009 CID_154699525 | ||
| 0.33 | 0.014 | 0.33 | Protein-tyrosine phosphatase inhibitor | 0.271 0.025 CID_154699525 | ||
| 0.345 | 0.034 | 0.753 | Angiogenesis stimulant | 0.753 0.004 CID_154699525 | CID_154699525 | |
| 0.344 | 0.035 | 0.421 | Vasodilator | 0.421 0.02 CID_154699525 | CID_154699525 | |
| 0.364 | 0.057 | 0.364 | Streptokinase A inhibitor | |||
| 0.323 | 0.019 | 0.323 | Mcl-1 antagonist | 0.136 0.104 CID_154699525 | ||
| 0.321 | 0.02 | 0.457 | DNA methyltransferase I inhibitor | 0.457 0.005 CID_154699525 | CID_154699525 | |
| 0.325 | 0.025 | 0.325 | Dual specificity phosphatase inhibitor | |||
| 0.316 | 0.017 | 0.316 | Cholinergic | |||
| 0.363 | 0.071 | 0.363 | Thioredoxin glutathione reductase inhibitor | |||
| 0.294 | 0.008 | 0.294 | Carbonic anhydrase XV inhibitor | |||
| 0.289 | 0.004 | 0.289 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.288 | 0.012 | 0.288 | 5-Lipoxygenase inhibitor | |||
| 0.397 | 0.121 | 0.397 | DNA polymerase beta inhibitor | |||
| 0.282 | 0.01 | 0.282 | Interleukin 4 antagonist | 0.21 0.02 CID_154699525 | ||
| 0.295 | 0.029 | 0.447 | DNA methylase inhibitor | 0.447 0.008 CID_154699525 | CID_154699525 | |
| 0.273 | 0.013 | 0.273 | Protein-tyrosine phosphatase 1B inhibitor | 0.242 0.018 CID_154699525 | ||
| 0.264 | 0.005 | 0.338 | Photosensitizer | 0.338 0.004 CID_154699525 | CID_154699525 | |
| 0.261 | 0.004 | 0.261 | Xanthine dehydrogenase inhibitor | 0.146 0.008 CID_154699525 | ||
| 0.276 | 0.019 | 0.276 | Nitric-oxide synthase stimulant | 0.271 0.021 CID_154699525 | ||
| 0.27 | 0.014 | 0.34 | Topoisomerase I inhibitor | 0.34 0.008 CID_154699525 | CID_154699525 | |
| 0.265 | 0.009 | 0.265 | GABA C receptor rho-2 antagonist | |||
| 0.264 | 0.01 | 0.264 | Antibacterial (Helicobacter pylori) | 0.151 0.045 CID_154699525 | ||
| 0.268 | 0.014 | 0.417 | Hexokinase inhibitor | 0.417 0.004 CID_154699525 | CID_154699525 | |
| 0.267 | 0.017 | 0.267 | Succinate dehydrogenase inhibitor | |||
| 0.263 | 0.015 | 0.263 | Chelator | 0.114 0.06 CID_154699525 | ||
| 0.251 | 0.009 | 0.251 | Carbonic anhydrase III inhibitor | 0.144 0.031 CID_154699525 | ||
| 0.245 | 0.005 | 0.245 | Multidrug resistance-associated protein 1 inhibitor | 0.216 0.008 CID_154699525 | ||
| 0.368 | 0.13 | 0.368 | DNA directed DNA polymerase inhibitor | |||
| 0.239 | 0.006 | 0.239 | Creatine kinase inhibitor | |||
| 0.266 | 0.044 | 0.45 | Platelet adhesion inhibitor | 0.45 0.008 CID_154699525 | CID_154699525 | |
| 0.256 | 0.035 | 0.256 | I kappa B kinase epsilon inhibitor | |||
| 0.282 | 0.066 | 0.282 | Transcription factor STAT inhibitor | |||
| 0.227 | 0.014 | 0.227 | Interleukin 1b antagonist | 0.17 0.028 CID_154699525 | ||
| 0.215 | 0.006 | 0.215 | Aldose reductase inhibitor | 0.188 0.008 CID_154699525 | ||
| 0.211 | 0.004 | 0.211 | Fatty acid synthase inhibitor | 0.11 0.008 CID_154699525 | ||
| 0.215 | 0.009 | 0.215 | MAP kinase kinase 4 inhibitor | 0.14 0.083 CID_154699525 | ||
| 0.264 | 0.062 | 0.264 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.219 | 0.02 | 0.219 | Neurotrophic factor | 0.181 0.037 CID_154699525 | ||
| 0.253 | 0.058 | 0.253 | Antimitotic | 0.151 0.12 CID_154699525 | ||
| 0.203 | 0.008 | 0.418 | DNA repair enzyme inhibitor | 0.418 0.003 CID_154699525 | CID_154699525 | |
| 0.207 | 0.013 | 0.24 | Carbonic anhydrase XIII inhibitor | 0.24 0.009 CID_154699525 | CID_154699525 | |
| 0.238 | 0.044 | 0.238 | Dual specificity phosphatase 3 inhibitor | |||
| 0.22 | 0.028 | 0.22 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.252 | 0.063 | 0.386 | Cyclic AMP phosphodiesterase inhibitor | 0.386 0.019 CID_154699525 | CID_154699525 | |
| 0.198 | 0.009 | 0.198 | Aromatase inhibitor | |||
| 0.249 | 0.06 | 0.249 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.207 | 0.02 | 0.207 | Toll-Like receptor 2 antagonist | |||
| 0.191 | 0.005 | 0.191 | Estrogen receptor beta agonist | 0.121 0.009 CID_154699525 | ||
| 0.26 | 0.076 | 0.26 | Transcription factor STAT3 inhibitor | |||
| 0.2 | 0.021 | 0.2 | Butyrylcholinesterase inhibitor | |||
| 0.192 | 0.014 | 0.192 | Carbonic anhydrase VI inhibitor | 0.091 0.046 CID_154699525 | ||
| 0.197 | 0.021 | 0.544 | Expectorant | 0.544 0.003 CID_154699525 | CID_154699525 | |
| 0.204 | 0.031 | 0.204 | Interleukin 1 antagonist | 0.122 0.085 CID_154699525 | ||
| 0.175 | 0.007 | 0.175 | Alpha tubulin antagonist | |||
| 0.18 | 0.013 | 0.18 | Urease inhibitor | |||
| 0.242 | 0.076 | 0.242 | Dyrk kinase inhibitor | |||
| 0.195 | 0.033 | 0.212 | Mannose-6-phosphate isomerase inhibitor | 0.212 0.025 CID_154699525 | CID_154699525 | |
| 0.177 | 0.015 | 0.177 | Protein kinase C zeta inhibitor | |||
| 0.164 | 0.003 | 0.164 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.239 | 0.079 | 0.239 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.166 | 0.01 | 0.166 | Beta tubulin antagonist | |||
| 0.16 | 0.005 | 0.16 | Estrogen receptor alpha agonist | 0.045 0.019 CID_154699525 | ||
| 0.173 | 0.017 | 0.202 | Uric acid excretion stimulant | 0.202 0.013 CID_154699525 | CID_154699525 | |
| 0.171 | 0.017 | 0.177 | Heat shock protein 70 antagonist | 0.177 0.013 CID_154699525 | CID_154699525 | |
| 0.266 | 0.113 | 0.266 | Thyroid hormone antagonist | |||
| 0.17 | 0.018 | 0.17 | Telomerase inhibitor | |||
| 0.241 | 0.09 | 0.241 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.19 | 0.039 | 0.19 | Cyclooxygenase 1 inhibitor | 0.132 0.069 CID_154699525 | ||
| 0.194 | 0.048 | 0.194 | Phospholipase C inhibitor | 0.17 0.073 CID_154699525 | ||
| 0.211 | 0.066 | 0.211 | Neurotrophic factor enhancer | 0.204 0.073 CID_154699525 | ||
| 0.298 | 0.156 | 0.298 | Transcription factor inhibitor | |||
| 0.188 | 0.046 | 0.363 | Protein kinase stimulant | 0.363 0.011 CID_154699525 | CID_154699525 | |
| 0.205 | 0.068 | 0.205 | Insulin sensitizer | 0.168 0.11 CID_154699525 | ||
| 0.181 | 0.047 | 0.306 | Insulin secretagoues | 0.306 0.012 CID_154699525 | CID_154699525 | |
| 0.181 | 0.047 | 0.181 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.157 | 0.024 | 0.375 | AMP-activated protein kinase stimulant | 0.375 0.004 CID_154699525 | CID_154699525 | |
| 0.143 | 0.012 | 0.143 | Myeloperoxidase inhibitor | |||
| 0.138 | 0.008 | 0.138 | D-Ala-D-Ala ligase inhibitor | |||
| 0.229 | 0.098 | 0.229 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.145 | 0.015 | 0.145 | Keratolytic | |||
| 0.135 | 0.007 | 0.135 | Carbonic anhydrase VII inhibitor | 0.061 0.019 CID_154699525 | ||
| 0.155 | 0.03 | 0.275 | Antineoplastic antibiotic | 0.275 0.012 CID_154699525 | CID_154699525 | |
| 0.127 | 0.002 | 0.127 | Estrogen-related receptor beta antagonist | 0.053 0.005 CID_154699525 | ||
| 0.163 | 0.039 | 0.163 | Cholesterol synthesis inhibitor | 0.111 0.074 CID_154699525 | ||
| 0.177 | 0.053 | 0.177 | Cyclooxygenase inhibitor | 0.129 0.088 CID_154699525 | ||
| 0.163 | 0.039 | 0.163 | Proteasome inhibitor | |||
| 0.132 | 0.009 | 0.132 | Phosphodiesterase VI inhibitor | 0.124 0.011 CID_154699525 | ||
| 0.141 | 0.02 | 0.141 | ABCA1 expression enhancer | |||
| 0.135 | 0.016 | 0.135 | HIV-1 integrase (3'-Processing) inhibitor | 0.094 0.028 CID_154699525 | ||
| 0.133 | 0.013 | 0.133 | Lipase inhibitor | 0.089 0.035 CID_154699525 | ||
| 0.212 | 0.093 | 0.212 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.195 | 0.077 | 0.195 | Histone acetyltransferase inhibitor | |||
| 0.181 | 0.066 | 0.181 | Tumour necrosis factor antagonist | |||
| 0.288 | 0.174 | 0.736 | Cyclophilin D inhibitor | 0.736 0.011 CID_154699525 | CID_154699525 | |
| 0.192 | 0.078 | 0.421 | Non-steroidal antiinflammatory agent | 0.421 0.011 CID_154699525 | CID_154699525 | |
| 0.17 | 0.057 | 0.306 | Interferon gamma antagonist | 0.306 0.019 CID_154699525 | CID_154699525 | |
| 0.139 | 0.026 | 0.139 | GABA C receptor rho-1 antagonist | |||
| 0.154 | 0.045 | 0.326 | Cyclooxygenase 3 inhibitor | 0.326 0.005 CID_154699525 | CID_154699525 | |
| 0.238 | 0.132 | 0.368 | Angiogenesis inhibitor | 0.368 0.064 CID_154699525 | CID_154699525 | |
| 0.279 | 0.175 | 0.279 | Calcium channel L-type activator | |||
| 0.108 | 0.005 | 0.108 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.119 | 0.017 | 0.119 | HIV-1 integrase (Strand Transfer) inhibitor | 0.085 0.029 CID_154699525 | ||
| 0.114 | 0.012 | 0.114 | CDC25B inhibitor | |||
| 0.105 | 0.005 | 0.105 | Transcription factor RelA inhibitor | |||
| 0.29 | 0.192 | 0.29 | MAP kinase 1 inhibitor | |||
| 0.186 | 0.088 | 0.186 | Psychostimulant | 0.169 0.101 CID_154699525 | ||
| 0.132 | 0.035 | 0.132 | Potassium channel (Ca-activated) activator | |||
| 0.124 | 0.028 | 0.14 | Thioredoxin inhibitor | 0.14 0.02 CID_154699525 | CID_154699525 | |
| 0.101 | 0.008 | 0.101 | Potassium channel Kv1.3 blocker | |||
| 0.208 | 0.116 | 0.499 | Immunostimulant | 0.499 0.029 CID_154699525 | CID_154699525 | |
| 0.142 | 0.051 | 0.244 | Alkylator | 0.244 0.017 CID_154699525 | CID_154699525 | |
| 0.127 | 0.037 | 0.127 | Sphingomyelinase inhibitor | |||
| 0.163 | 0.075 | 0.163 | Neurotensin receptor agonist | |||
| 0.115 | 0.029 | 0.115 | CYP2A6 inhibitor | |||
| 0.098 | 0.012 | 0.098 | Glutamate (mGluR7) antagonist | |||
| 0.101 | 0.015 | 0.13 | Neuraminidase inhibitor | 0.13 0.008 CID_154699525 | CID_154699525 | |
| 0.131 | 0.045 | 0.143 | Mucolytic | 0.143 0.036 CID_154699525 | CID_154699525 | |
| 0.164 | 0.081 | 0.164 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.099 | 0.017 | 0.1 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.1 0.017 CID_154699525 | CID_154699525 | |
| 0.216 | 0.134 | 0.216 | Insulysin inhibitor | |||
| 0.22 | 0.139 | 0.22 | Thyroid hormone beta antagonist | |||
| 0.123 | 0.043 | 0.123 | Electron transport complex I inhibitor | |||
| 0.104 | 0.024 | 0.104 | Leukotriene synthesis inhibitor | |||
| 0.102 | 0.028 | 0.102 | Cyclin B3 inhibitor | |||
| 0.237 | 0.163 | 0.237 | Calcium channel activator | |||
| 0.101 | 0.028 | 0.101 | Thioredoxin reductase inhibitor | |||
| 0.096 | 0.026 | 0.096 | Potassium channel large-conductance Ca-activated activator | |||
| 0.089 | 0.019 | 0.089 | Aryl hydrocarbon receptor antagonist | |||
| 0.102 | 0.032 | 0.102 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.114 | 0.05 | 0.171 | Toll-Like receptor 4 antagonist | 0.171 0.012 CID_154699525 | CID_154699525 | |
| 0.072 | 0.009 | 0.072 | Estrogen-related receptor alpha antagonist | |||
| 0.092 | 0.03 | 0.092 | HIV-1 integrase inhibitor | |||
| 0.094 | 0.031 | 0.094 | CDC25A inhibitor | |||
| 0.117 | 0.056 | 0.117 | GABA C receptor antagonist | |||
| 0.082 | 0.024 | 0.135 | Neuraminidase (influenza) inhibitor | 0.135 0.009 CID_154699525 | CID_154699525 | |
| 0.129 | 0.071 | 0.129 | Cyclooxygenase 2 inhibitor | |||
| 0.116 | 0.06 | 0.176 | DNA intercalator | 0.176 0.033 CID_154699525 | CID_154699525 | |
| 0.067 | 0.012 | 0.067 | Cholesterol esterase inhibitor | |||
| 0.146 | 0.093 | 0.146 | Arachidonic acid antagonist | |||
| 0.116 | 0.064 | 0.116 | TRPA1 agonist | |||
| 0.106 | 0.055 | 0.106 | Anabolic | |||
| 0.139 | 0.088 | 0.139 | Phospholipase A2 inhibitor | 0.121 0.115 CID_154699525 | ||
| 0.126 | 0.075 | 0.126 | Vanilloid 1 agonist | 0.122 0.083 CID_154699525 | ||
| 0.131 | 0.081 | 0.131 | Farnesoid X receptor antagonist | |||
| 0.137 | 0.087 | 0.137 | Ca2+-transporting ATPase inhibitor | 0.132 0.107 CID_154699525 | ||
| 0.066 | 0.017 | 0.066 | CD45 antagonist | |||
| 0.102 | 0.053 | 0.102 | Prolactin inhibitor | |||
| 0.106 | 0.057 | 0.106 | Bronchodilator | |||
| 0.096 | 0.05 | 0.096 | Androgen antagonist | |||
| 0.072 | 0.026 | 0.072 | Cyclin D1 inhibitor | |||
| 0.056 | 0.012 | 0.056 | DNA gyrase subunit A inhibitor | |||
| 0.087 | 0.043 | 0.117 | Na+ K+ transporting ATPase inhibitor | 0.117 0.018 CID_154699525 | CID_154699525 | |
| 0.084 | 0.04 | 0.12 | Histone deacetylase SIRT1 stimulant | 0.12 0.017 CID_154699525 | CID_154699525 | |
| 0.084 | 0.04 | 0.12 | Histone deacetylase stimulant | 0.12 0.017 CID_154699525 | CID_154699525 | |
| 0.077 | 0.039 | 0.077 | Carbonic anhydrase VA inhibitor | |||
| 0.045 | 0.007 | 0.131 | Sodium/glucose cotransporter 2 inhibitor | 0.131 0.002 CID_154699525 | CID_154699525 | |
| 0.081 | 0.045 | 0.081 | GABA aminotransferase inhibitor | 0.078 0.049 CID_154699525 | ||
| 0.067 | 0.031 | 0.067 | Heat shock protein 90 beta antagonist | |||
| 0.066 | 0.031 | 0.066 | Alcohol oxidase inhibitor | |||
| 0.066 | 0.032 | 0.066 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.1 | 0.069 | 0.215 | Mediator release inhibitor | 0.215 0.013 CID_154699525 | CID_154699525 | |
| 0.041 | 0.012 | 0.041 | ATP citrate lysase inhibitor | |||
| 0.196 | 0.168 | 0.426 | Cholesterol antagonist | 0.426 0.045 CID_154699525 | CID_154699525 | |
| 0.124 | 0.096 | 0.152 | CC chemokine 6 receptor antagonist | 0.152 0.019 CID_154699525 | CID_154699525 | |
| 0.069 | 0.043 | 0.069 | Carbonic anhydrase V inhibitor | |||
| 0.065 | 0.04 | 0.065 | Protease activated receptor antagonist | |||
| 0.058 | 0.034 | 0.12 | Carbonic anhydrase XII inhibitor | 0.12 0.017 CID_154699525 | CID_154699525 | |
| 0.083 | 0.059 | 0.083 | Estrogen-related receptor beta agonist | |||
| 0.054 | 0.031 | 0.102 | Glucose-6-phosphate translocase inhibitor | 0.102 0.006 CID_154699525 | CID_154699525 | |
| 0.056 | 0.034 | 0.07 | Leukotriene B4 antagonist | 0.07 0.019 CID_154699525 | CID_154699525 | |
| 0.105 | 0.083 | 0.127 | Beta amyloid protein antagonist | 0.127 0.06 CID_154699525 | CID_154699525 | |
| 0.056 | 0.034 | 0.056 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.031 | 0.01 | 0.124 | Sodium/glucose cotransporter inhibitor | 0.124 0.002 CID_154699525 | CID_154699525 | |
| 0.105 | 0.085 | 0.105 | Interleukin 8 antagonist | |||
| 0.208 | 0.189 | 0.465 | Immunosuppressant | 0.465 0.043 CID_154699525 | CID_154699525 | |
| 0.069 | 0.05 | 0.069 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.203 | 0.184 | 0.203 | Sodium/bile acid cotransporter inhibitor | |||
| 0.17 | 0.152 | 0.17 | 5 Hydroxytryptamine release stimulant | |||
| 0.039 | 0.022 | 0.039 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.176 | 0.16 | 0.317 | DNA synthesis inhibitor | 0.317 0.038 CID_154699525 | CID_154699525 | |
| 0.061 | 0.046 | 0.08 | Nitric oxide donor | 0.08 0.022 CID_154699525 | CID_154699525 | |
| 0.051 | 0.036 | 0.051 | CXC chemokine 1 receptor antagonist | |||
| 0.114 | 0.101 | 0.114 | CDC-like kinase 1 inhibitor | |||
| 0.054 | 0.041 | 0.054 | Carbonic anhydrase VB inhibitor | |||
| 0.094 | 0.082 | 0.094 | Protein kinase (CK2) alpha inhibitor | |||
| 0.034 | 0.022 | 0.034 | Melatonin 2 agonist | |||
| 0.026 | 0.015 | 0.069 | Protein 30S ribosomal subunit inhibitor | 0.069 0.005 CID_154699525 | CID_154699525 | |
| 0.02 | 0.01 | 0.032 | Antibiotic Anthracycline-like | 0.032 0.003 CID_154699525 | CID_154699525 | |
| 0.057 | 0.048 | 0.057 | Adenosine A2a receptor antagonist | |||
| 0.016 | 0.008 | 0.016 | Antibiotic Tetracycline-like | |||
| 0.048 | 0.04 | 0.061 | Factor III inhibitor | 0.061 0.017 CID_154699525 | CID_154699525 | |
| 0.053 | 0.045 | 0.053 | Adenosine A1 receptor antagonist | |||
| 0.055 | 0.048 | 0.055 | Androgen agonist | |||
| 0.069 | 0.061 | 0.069 | Adenosine A3 receptor antagonist | |||
| 0.057 | 0.049 | 0.057 | Ryanodine receptor antagonist | |||
| 0.02 | 0.013 | 0.02 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.031 | 0.023 | 0.031 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.104 | 0.096 | 0.104 | Transcription factor STAT6 inhibitor | |||
| 0.107 | 0.102 | 0.107 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.066 | 0.061 | 0.066 | Glutamate decarboxylase inhibitor | |||
| 0.044 | 0.041 | 0.089 | Carbonic anhydrase XIV inhibitor | 0.089 0.014 CID_154699525 | CID_154699525 | |
| 0.042 | 0.04 | 0.042 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.019 | 0.018 | 0.019 | Estrone sulfatase inhibitor | |||
| 0.018 | 0.027 | 0.024 | Dopamine D1 agonist | 0.024 0.014 CID_154699525 | CID_154699525 | |
| 0.089 | 0.098 | 0.127 | DNA polymerase I inhibitor | 0.127 0.063 CID_154699525 | CID_154699525 | |
| 0.091 | 0.108 | 0.117 | Microtubule formation inhibitor | 0.117 0.064 CID_154699525 | CID_154699525 | |
| 0.082 | 0.101 | 0.104 | Phosphodiesterase 6D inhibitor | 0.104 0.045 CID_154699525 | CID_154699525 | |
| 0.076 | 0.097 | 0.159 | UDP-glucose 4-epimerase inhibitor | 0.159 0.026 CID_154699525 | CID_154699525 | |
| 0.038 | 0.06 | 0.051 | Glucose-6-phosphate isomerase inhibitor | 0.051 0.028 CID_154699525 | CID_154699525 | |
| 0.071 | 0.097 | 0.122 | NADH dehydrogenase inhibitor | 0.122 0.028 CID_154699525 | CID_154699525 | |
| 0.103 | 0.131 | 0.289 | Thrombolytic | 0.289 0.026 CID_154699525 | CID_154699525 | |
| 0.077 | 0.105 | 0.083 | Glutamate release inhibitor | 0.083 0.08 CID_154699525 | CID_154699525 | |
| 0.089 | 0.12 | 0.145 | Alpha-N-acetylglucosaminidase inhibitor | 0.145 0.058 CID_154699525 | CID_154699525 | |
| 0.099 | 0.139 | 0.195 | Diuretic | 0.195 0.046 CID_154699525 | CID_154699525 | |
| 0.149 | 0.195 | 0.364 | Peptidyltransferase inhibitor | 0.364 0.01 CID_154699525 | CID_154699525 | |
| 0.121 | 0.167 | 0.237 | ATPase inhibitor | 0.237 0.017 CID_154699525 | CID_154699525 | |
| 0.029 | 0.081 | 0.057 | Neuraminidase (Influenza A) inhibitor | 0.057 0.015 CID_154699525 | CID_154699525 | |
| 0.073 | 0.128 | 0.107 | Interleukin 12 antagonist | 0.107 0.043 CID_154699525 | CID_154699525 | |
| 0.01 | 0.073 | 0.036 | Arginase inhibitor | 0.036 0.025 CID_154699525 | CID_154699525 | |
| 0.061 | 0.129 | 0.102 | Triose-phosphate isomerase inhibitor | 0.102 0.046 CID_154699525 | CID_154699525 | |
| 0.16 | 0.236 | 0.564 | Antithrombotic | 0.564 0.02 CID_154699525 | CID_154699525 | |
| 0.033 | 0.109 | 0.08 | Phosphofructokinase-1 inhibitor | 0.08 0.041 CID_154699525 | CID_154699525 | |
| 0.097 | 0.179 | 0.31 | Hemostatic | 0.31 0.015 CID_154699525 | CID_154699525 | |
| 0.032 | 0.118 | 0.097 | Heparanase inhibitor | 0.097 0.004 CID_154699525 | CID_154699525 | |
| 0.066 | 0.153 | 0.084 | T cell inhibitor | 0.084 0.052 CID_154699525 | CID_154699525 | |
| 0.102 | 0.193 | 0.191 | Interleukin 6 antagonist | 0.191 0.047 CID_154699525 | CID_154699525 | |
| 0.04 | 0.159 | 0.061 | Lipocortins synthesis agonist | 0.061 0.033 CID_154699525 | CID_154699525 | |
| 0.021 | 0.141 | 0.095 | Protein 50S ribosomal subunit inhibitor | 0.095 0.014 CID_154699525 | CID_154699525 | |
| 0.02 | 0.143 | 0.068 | Antibiotic Aminoglycoside-like | 0.068 0.006 CID_154699525 | CID_154699525 | |
| 0.075 | 0.215 | 0.214 | Cell wall synthesis inhibitor | 0.214 0.025 CID_154699525 | CID_154699525 | |
| 0.047 | 0.188 | 0.109 | ATPase (Vacuolar H+) inhibitor | 0.109 0.028 CID_154699525 | CID_154699525 | |
| 0.02 | 0.186 | 0.053 | Alpha-mannosidase inhibitor | 0.053 0.037 CID_154699525 | CID_154699525 | |
| 0.08 | 0.256 | 0.222 | Hypolipemic | 0.222 0.081 CID_154699525 | CID_154699525 | |
| 0.033 | 0.226 | 0.057 | Adenine nucleotide translocase inhibitor | 0.057 0.034 CID_154699525 | CID_154699525 | |
| 0.013 | 0.207 | 0.041 | Mannosidase inhibitor | 0.041 0.038 CID_154699525 | CID_154699525 | |
| 0.062 | 0.306 | 0.202 | Interleukin agonist | 0.202 0.119 CID_154699525 | CID_154699525 | |
| 0.014 | 0.272 | 0.328 | Selectin antagonist | 0.328 0.004 CID_154699525 | CID_154699525 | |
| 0.038 | 0.385 | 0.189 | Cell adhesion inhibitor | 0.189 0.028 CID_154699525 | CID_154699525 | |
| 0.041 | 0.408 | 0.227 | Platelet antagonist | 0.227 0.083 CID_154699525 | CID_154699525 | |
| 0.012 | 0.39 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 CID_154699525 | CID_154699525 | |
| 0.034 | 0.481 | 0.105 | Transcription factor NF kappa B stimulant | 0.105 0.034 CID_154699525 | CID_154699525 | |
| 0.016 | 0.497 | 0.087 | Cell adhesion molecule inhibitor | 0.087 0.045 CID_154699525 | CID_154699525 | |
| 0.07 | 0.664 | 0.346 | Interleukin 2 agonist | 0.346 0.048 CID_154699525 | CID_154699525 | |
| 0.038 | 0.657 | 0.305 | Immunomodulator | 0.305 0.08 CID_154699525 | CID_154699525 | |
| 0.012 | 0.735 | 0.053 | Factor IXa inhibitor | 0.053 0.034 CID_154699525 | CID_154699525 | |
| 0.008 | 0.765 | 0.131 | Anticoagulant | 0.131 0.099 CID_154699525 | CID_154699525 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |